Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Dallas, Texas 75204


The purposes of this study are to determine whether pemetrexed can help patients with metastatic (cancer that has spread to other parts of the body) breast cancer, to determine any side effects that may be associated with the drug, to determine how much pemetrexed should be given to patients, and to collect DNA for future research regarding metastatic breast cancer. The collection of DNA is optional to the patient.


Inclusion Criteria: - Must have been diagnosed with either advanced or metastatic breast cancer. - Chemotherapy has not been given for advanced or metastatic breast cancer. - The diagnosis of advanced or metastatic breast cancer was made at least 12 months after chemotherapy was given after breast surgery. - Able to carry out work of a light nature (for example, light housework, office work). - Must be at least 18 years old. Exclusion Criteria: - Have received prior bone marrow or peripheral stem cell transplantation. - Have received prior chemotherapy for metastatic breast cancer. - Are currently pregnant or breast-feeding. - Have an active infection that your doctor decides will affect your safety. - Are unable to take folic acid or vitamin B12.



Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company

Backup Contact:


Location Contact:

Dallas, Texas 75204
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.